Equities researchers at StockNews.com began coverage on shares of Mannatech (NASDAQ:MTEX – Get Free Report) in a report released on Thursday. The firm set a “buy” rating on the stock.
Mannatech Trading Up 5.3 %
NASDAQ MTEX opened at $8.35 on Thursday. The company has a quick ratio of 0.74, a current ratio of 1.25 and a debt-to-equity ratio of 0.44. The stock’s 50-day simple moving average is $10.75 and its two-hundred day simple moving average is $10.09. Mannatech has a twelve month low of $6.75 and a twelve month high of $16.49. The company has a market capitalization of $15.87 million, a price-to-earnings ratio of -10.31 and a beta of 0.98.
Mannatech (NASDAQ:MTEX – Get Free Report) last announced its quarterly earnings data on Wednesday, March 26th. The company reported $1.20 earnings per share for the quarter. Mannatech had a negative return on equity of 15.62% and a negative net margin of 1.26%. The company had revenue of $29.01 million for the quarter.
Mannatech Company Profile
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Featured Stories
- Five stocks we like better than Mannatech
- Market Cap Calculator: How to Calculate Market Cap
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- Are Penny Stocks a Good Fit for Your Portfolio?
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- What Are Dividends? Buy the Best Dividend Stocks
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
